Home › Funds › EDGEWOOD MANAGEMENT LLC › ABT

EDGEWOOD MANAGEMENT LLC position in ABT

ABBOTT LABORATORIES · Health Care

EDGEWOOD MANAGEMENT LLC reported holding 68,016 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 0.11% of its reported portfolio and ranking #31 among its reported holdings. EDGEWOOD MANAGEMENT LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)68.02K sh
Reported value held$6.72M
Portfolio Weight0.11%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EDGEWOOD MANAGEMENT LLC's ABT position evolved

EDGEWOOD MANAGEMENT LLC first disclosed a stake in ABT in Q3 2023 at 72,130 shares (US$7.0M). The position peaked in Q2 2025 at 68,016 shares, worth US$9.3M. Across 13 filings, EDGEWOOD MANAGEMENT LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 68,016 shares valued at US$6.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 72.13K $6.99M New
Q4 2023 72.13K $7.94M Hold
Q1 2024 72.13K $8.20M Hold
Q2 2024 72.13K $7.50M Hold
Q3 2024 68.02K $7.75M Reduce
Q4 2024 68.02K $7.69M Hold
Q1 2025 68.02K $9.02M Hold
Q2 2025 68.02K $9.25M Hold
Q3 2025 68.02K $9.11M Hold
Q4 2025 68.02K $8.52M Hold
Q1 2026 68.02K $6.98M Hold
Q2 2026 68.02K $6.17M Hold
Q3 2026 68.02K $6.72M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has EDGEWOOD MANAGEMENT LLC held ABT?

EDGEWOOD MANAGEMENT LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EDGEWOOD MANAGEMENT LLC's current position in ABT?

As of Q3 2026, EDGEWOOD MANAGEMENT LLC holds 68.02K shares of ABT (ABBOTT LABORATORIES), valued at $6.72M, representing 0.11% of its reported portfolio and ranking #31.

Has EDGEWOOD MANAGEMENT LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), EDGEWOOD MANAGEMENT LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 68.02K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.